IL-12 heterodimeric Fc-fusion proteins

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12234270
APP PUB NO 20220396605A1
SERIAL NO

17718087

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides novel IL-12 Fc fusion proteins, methods of making and using the same. The IL-12 Fc fusion proteins are useful for treatment of cancer and can be used in combination with checkpoint blockade.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XENCOR INC111 WEST LEMON AVENUE MONROVIA CA 91016

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bernett, Matthew Monrovia, US 72 1505
Desjarlais, John R Pasadena, US 195 6468
Hassanzadeh-Kiabi, Nargess Pasadena, US 5 10
Liu, Ke Glendora, US 298 2562
Rashid, Rumana Temple City, US 75 1525
Varma, Rajat Hamden, US 31 158

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 25, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 25, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 25, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00